Back | Next |
home / stock / imtx / imtx message board
Subject | By | Source | When |
---|---|---|---|
must see | Solarfuture | investorshub | 04/03/2023 5:03:07 PM |
$IMTX What do you make of this? | FACT-MASTER | investorshub | 04/02/2023 6:54:22 AM |
Yes, it was (a strategic decision) https://www.fiercebiotech.com/biotech/no-regr | jondoeuk | investorshub | 03/19/2023 7:45:27 PM |
Did you notice this? | FACT-MASTER | investorshub | 02/14/2023 3:49:07 AM |
Good sign! Only question of time this will run... | Solarfuture | investorshub | 02/09/2023 12:56:08 PM |
https://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-neur | FACT-MASTER | investorshub | 02/08/2023 10:56:54 PM |
$HUGE INCREASE in institutional holdings | FACT-MASTER | investorshub | 02/07/2023 10:06:27 PM |
Volume and stock price turning positive! | FACT-MASTER | investorshub | 02/02/2023 2:08:40 AM |
Nice new presentation on the website... | Solarfuture | investorshub | 01/09/2023 12:50:40 PM |
$IMTX Article 12/21/22 | FACT-MASTER | investorshub | 12/21/2022 11:16:15 PM |
PPS not to understand here...great chances for new investors... | Solarfuture | investorshub | 12/16/2022 2:44:55 PM |
Solid support on the BID | FACT-MASTER | investorshub | 12/08/2022 8:57:36 PM |
Another article: | FACT-MASTER | investorshub | 12/02/2022 4:04:12 AM |
What i found interesting about the interim data | FACT-MASTER | investorshub | 12/02/2022 3:19:34 AM |
Interesting article here: | FACT-MASTER | investorshub | 12/02/2022 3:03:31 AM |
Thank u! In the near future I think | Solarfuture | investorshub | 11/24/2022 6:40:28 PM |
FY 2022 earnings estimate update: | FACT-MASTER | investorshub | 11/24/2022 3:43:52 PM |
Interesting info here regarding a Phase 2 trial | FACT-MASTER | investorshub | 11/23/2022 1:46:38 AM |
$IMTX Top 5 Institutional Holders: | FACT-MASTER | investorshub | 11/22/2022 10:21:07 PM |
TCR Bispecifics Programs | FACT-MASTER | investorshub | 11/19/2022 2:41:26 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-12 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Company Provides Clinical Data Update from Ongoing Phase 1 Clinical Trial with ACTengine® IMA203 TCR-T Targeting PRAME Updated clinical data on ACTengine® IMA203 targeting PRAME in 30 heavily pre-treated metastatic melanoma patients at RP2D: 55% confirmed objective r...
2024-04-02 14:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...